LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research

November 08, 2024 08:46 AM AEDT | By EIN Presswire
 LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research
Image source: EIN Presswire
MOUNTAIN VIEW, CA, UNITED STATES, November 7, 2024 /EINPresswire.com/ -- LifeScience PLUS is proud to announce its new publication of a pivotal study titled “Regulating Tissue Growth Factors for Healing with Etherified Carboxymethylcellulose Matrix” in The Journal of Burn Care and Research (link: https://pubmed.ncbi.nlm.nih.gov/38953221/), showcasing the remarkable potential of Etherified Carboxymethylcellulose Matrix (eCMC) technology, the proprietary ingredient in their groundbreaking hemostatic and wound healing dressings.

This study was initiated to elucidate the mechanisms behind the observations of leading burn and trauma surgeons that donor sites healed 4 times faster with the use of BloodSTOP iX / DonorSeal than by the use of their traditional protocols. The study, performed by burn, trauma, and urology surgeons and researchers at OSF Rockford Hospital and UCSF , highlights the dual action of eCMC both in promoting wound healing and mitigating infection or inflammation risks. By establishing a rat burn model and administering eCMC, researchers analyzed cytokines and inflammatory mediators using a Cytokine Array and histochemical staining.

Key findings from the study include:
• eCMC significantly induces the expression of endogenous cytokines, particularly Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF).
• eCMC effectively inhibits inflammatory cytokines such as Cytokine-Induced Neutrophil Chemoattractant (CINC-1, CINC-2) and Matrix Metallopeptidase 8 (MMP-8).

These dual actions facilitate wound healing and reduce the risk of infection, both validating the clinical results and demonstrating the efficacy of eCMC for enhancing skin regeneration.

The study concludes that eCMC emerges as an ideal solution for wound hemostasis and healing. By inducing a range of endogenous cytokines, with particular emphasis on VEGF and PDGF, eCMC plays a vital role in accelerating tissue healing. Simultaneously, it effectively inhibits inflammatory cytokines such as CINC-1, CINC-2, and MMP-8, thereby reducing the risk of wound infection and facilitating the healing process.

LifeScience PLUS offers a full product line total wound care solutions utilizing eCMC technology, including BloodSTOP® iX, DonorSeal™ and Trauma Matrix® Advanced Hemostat. These products are designed for a variety of wound types and known for their ability to deliver rapid hemostasis and promote effective healing.

For more information about the study or LifeScience PLUS, please visit www.lifescienceplus.com.

About LifeScience PLUS
LifeScience PLUS is a leading global provider of advanced hemostatic and wound healing solutions. With products powered by eCMC technology, LifeScience PLUS’s product portfolio is clinically proven and 100% plant-based designed to enhance wound care and tissue regeneration. LifeScience PLUS is committed to delivering innovative solutions that improve patient wound care and outcomes.

Jennifer Xu
LifeScience PLUS
+1 650-565-8172
email us here
Visit us on social media:
Facebook
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.